“…As a result, it is recommended that transgender individuals be treated according to published guidelines for cisgender individuals 34,35 . Given that TABLE I Recommendations for Bone Density Testing in TGNC Individuals* Baseline BMD testing is indicated for TGNC individuals with a history of gonadectomy or antiandrogen use without appropriate GAHT supplementation; hypogonadism with the intention of using GAHT; or other indications for BMD testing not related to GAHT (e.g., prolonged glucocorticoid use) 28 Baseline bone density testing is recommended for transgender youth before initiating GnRHa monotherapy 20 Follow-up BMD testing should be conducted in TGNC individuals at risk of bone loss (or with preexisting low BMD), such as individuals not taking adequate doses of GAHT or planning to discontinue GAHT 18,28,29 TGNC individuals on an appropriate regimen of GAHT with no additional bone loss risk factors younger than 50 years do not need routine BMD testing 18,29 Transgender youth receiving GnRHa monotherapy should undergo BMD testing every 1 to 2 years while receiving GnRHa 12 . Once trans youth have started GAHT in addition to GnRHa, BMD testing should be performed every 1 to 2 years until the ages of approximately 25 or 30 years 13 *BMD 5 bone mineral density, GAHT 5 gender-affirming hormone therapy, GnRHa 5 gonadotropin-releasing hormone analog, and TGNC 5 transgender and gender-nonconforming.…”